Use of a benzoate containing composition to treat glycine encephalopathy
AssigneeRush University Medical Center
InventorKalipada Pahan
Life of this patent
Estimating the term…
Abstract
This disclosure relates to pharmaceutical compositions and formulations useful for inhibiting the progression of glycine encephalopathy. The pharmaceutical compositions and formulations may include glyceryl tribenzoate. The pharmaceutical compositions and formulations may include glyceryl dibenzoate. The pharmaceutical compositions and formulations may be orally administered to the patient.
Claims16
A method for inhibiting the progression of glycine encephalopathy, comprising:
- administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising glyceryl tribenzoate.
A method for inhibiting the progression of glycine encephalopathy, comprising:
- administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising glyceryl dibenzoate.
A method of using a formulation for inhibiting the progression of glycine encephalopathy, comprising:
- administering to a patient in need thereof an effective amount of the formulation, the formulation comprising about 1 gram/1 ml of glyceryl tribenzoate.
Dependencies are inferred from the claim text.